Medi Assist Ser.
Medi Assist Ser. Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Core group business organic growth currently tracking at 8%-10% (same-store growth). Medi Assist expects continued growth driven by core TPA business, technology SaaS platform, international business, and new acquisitions (e.g., Paramount).
From Medi Assist Ser.'s Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Core group business organic growth currently tracking at 8%-10% (same-store growth).
- Historical post-COVID same-store growth peaked at 20%-25%, now moderating.
- Growth rates influenced by IT-ITES slowdown; other industries like oil & gas, chemical, manufacturing showing promising life growth.
- Technology SaaS platform revenue grew 91.9% YoY, contributing 2.5% of total revenue, expected to scale further.
- International business pipeline built; markets like Southeast Asia targeted for expansion.
- Expected technology business to achieve 1.5x to 2x higher margin than traditional TPA business.
- Paramount acquisition integration expected to complete in 1-2 quarters, improving margins.
- Government business growing strongly (42.6% YoY), with increasing public health engagement.
2 more points from Medi Assist Ser.'s call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Medi Assist Ser. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The transcript does not explicitly mention any specific current or planned capex or capital investments.
- The company is focused on technology development, particularly AI and SaaS platforms, which are implied investments in tech capabilities.
- There is significant emphasis on integration of acquisitions (e.g., Paramount) over 4-5 quarters, which may involve some strategic investments related to operational scaling.
- Expansion into international markets like Southeast Asia and Thailand suggests potential strategic investments in those regions.
2 more points from Medi Assist Ser.'s call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Medi Assist Ser. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As per the transcript, Medi Assist Healthcare Services Limited disclosed a contract liability of INR 280.2 crores as of March 31, 2026.
- This contract liability represents revenue that is committed but has not yet been recognized in the Profit & Loss statement.
- The contract liability can be understood as the current order book or pending revenue from signed contracts that will be recognized in future periods.
2 more points from Medi Assist Ser.'s call on order book
Pro opens every point from 15K+ earnings calls
Medi Assist Ser. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹242 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medi Assist Healthcare Services Ltd's management said in earlier quarters
Others in Insurance this season
- Max Financial Services Ltd (Q4 FY26)
Total APE (Annualized Premium Equivalent) for FY’26: Rs 10,502 crore, up 20% YoY from Rs 8,770 crore in FY’25 (Page 4). Key investor presentation takeaways from
- New India Assurance Company Ltd (Q4 FY26)
Domestic gross direct premium grew by 10.9% in FY26, with a market share increase from 12.56% to 12.74%. Key concall takeaways from New India Assurance Company…
- Go Digit General Insurance Ltd (Q4 FY26)
For fiscal years '25 and '26, retail health business is under 6% of total health segment, indicating room for growth. Key concall takeaways from Go Digit…
- Niva Bupa Health Insurance Company Ltd (Q4 FY26)
16,000 crores, up from INR 9,433 crores in FY '26. Key concall takeaways from Niva Bupa Health's Q4 FY26 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Medi Assist Ser. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Medi Assist Ser. Q4 FY26 results?
Core group business organic growth currently tracking at 8%-10% (same-store growth). Medi Assist expects continued growth driven by core TPA business, technology SaaS platform, international business, and new acquisitions (e.g., Paramount).
What is Medi Assist Ser. share price analysis?
Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹2,605 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medi Assist Ser. planning capital expenditure?
The transcript does not explicitly mention any specific current or planned capex or capital investments.
Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.